Skip to content
Search

Latest Stories

Shehnaaz Gill teams up with Diljit Dosanjh for the Punjabi movie Honsla Rakh

Shehnaaz Gill teams up with Diljit Dosanjh for the Punjabi movie Honsla Rakh

By Murtuza Iqbal

Shehnaaz Gill became a household name because of her stint in the Bigg Boss season 13. She was the second runner-up of the season and was mainly known for her romantic feelings towards Sidharth Shukla.


After coming out from the Bigg Boss house, Shehnaaz has featured in many music videos, but now, she is all set to play one of the leads in Diljit Dosanjh’s Honsla Rakh.

Diljit makes his debut as a producer with Honsla Rakh and today, he took to Instagram to make an announcement about the film. He posted, “This Dusshera #HonslaRakh, 15th Oct, 2021!! @sonambajwa @shehnaazgill @humblekids_ @thindmotionfilms #Storytimeproductions @amarjitsaron @thepawangill @onlyrakeshdhawan @bal_deo @sonalisingh #TeamDosanjh.”

Diljit has named his production house Story Time Productions and the shooting of Honsla Rakh kickstarts in Vancouver, Canada. Apart from Diljit and Shehnaaz, the movie also stars Sonam Bajwa and Shinda Grewal. It will be directed by Amarjit Singh Saron and the film is slated to hit the big screens on Dussehra this year (15th October 2021).

After her stint in Bigg Boss 13, Shehnaaz has a huge fan following, and we are sure her fans would be excited to see her on the big screen alongside Diljit Dosanjh. She has earlier worked in Punjabi movies like Sat Shri Akaal England, Kala Shah Kala and Daaka.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less